- Home
- ARQT vs AMR Comparison
ARQT vs AMR Comparison
Compare ARQT & AMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARQT | AMR |
|---|---|---|
| Founded | 2016 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Coal Mining |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.5B |
| IPO Year | 2020 | 2017 |
Fundamental Metrics
Financial Performance| Metric | ARQT | AMR |
|---|---|---|
| Price | $23.69 | $195.89 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 4 |
| Target Price | $34.00 | ★ $181.50 |
| AVG Volume (30 Days) | ★ 1.7M | 240.2K |
| Earning Date | 05-06-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 88.79 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $376,072,000.00 | ★ $2,129,481,000.00 |
| Revenue This Year | $34.85 | $15.05 |
| Revenue Next Year | $29.39 | $14.78 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 91.34 | N/A |
| 52 Week Low | $12.72 | $104.42 |
| 52 Week High | $31.77 | $253.82 |
Technical Indicators
Market Signals| Indicator | ARQT | AMR |
|---|---|---|
| Relative Strength Index (RSI) | 62.23 | 49.76 |
| Support Level | $22.41 | $176.09 |
| Resistance Level | $23.87 | $212.15 |
| Average True Range (ATR) | 0.85 | 12.57 |
| MACD | 0.34 | -0.04 |
| Stochastic Oscillator | 91.83 | 49.66 |
Price Performance
Historical ComparisonAbout ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.
About AMR Alpha Metallurgical Resources Inc.
Alpha Metallurgical Resources Inc is a Tennessee-based coal mining company with operations across Virginia and West Virginia. The company's portfolio of mining operations consists of underground mines, surface mines, and coal preparation plants. It produces low-ash metallurgical coal, including High-Vol. A, Mid-Vol., High-Vol. B, and Low-Vol. coal, which is shipped to domestic and international coke and steel producers. The reportable segment of the company is Met. It extracts, processes and markets met and thermal coal from deep and surface mines for sale to steel and coke producers, industrial customers, and electric utilities.